CA1063937A - Composition containing n4-acylcytosine arabinosides and process for preparation thereof - Google Patents

Composition containing n4-acylcytosine arabinosides and process for preparation thereof

Info

Publication number
CA1063937A
CA1063937A CA268,779A CA268779A CA1063937A CA 1063937 A CA1063937 A CA 1063937A CA 268779 A CA268779 A CA 268779A CA 1063937 A CA1063937 A CA 1063937A
Authority
CA
Canada
Prior art keywords
additive
water
solvent
acylcytosine
arabinoside
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
CA268,779A
Other languages
English (en)
French (fr)
Inventor
Torao Ishida
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Asahi Kasei Corp
Original Assignee
Asahi Kasei Kogyo KK
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP50158551A external-priority patent/JPS5840528B2/ja
Priority claimed from JP399276A external-priority patent/JPS5290615A/ja
Priority claimed from JP10066876A external-priority patent/JPS5326317A/ja
Application filed by Asahi Kasei Kogyo KK filed Critical Asahi Kasei Kogyo KK
Application granted granted Critical
Publication of CA1063937A publication Critical patent/CA1063937A/en
Expired legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/10Dispersions; Emulsions
    • A61K9/107Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Biophysics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
CA268,779A 1975-12-31 1976-12-29 Composition containing n4-acylcytosine arabinosides and process for preparation thereof Expired CA1063937A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP50158551A JPS5840528B2 (ja) 1975-12-31 1975-12-31 N4− ベヘノイルシトシンアラビノシドノスイヨウカホウホウ
JP399276A JPS5290615A (en) 1976-01-19 1976-01-19 Water-soluble solid and aqueous solution of n4-acylcytosine arabinosid e
JP10066876A JPS5326317A (en) 1976-08-25 1976-08-25 Composition containing n4-acylcytosine arabinoside

Publications (1)

Publication Number Publication Date
CA1063937A true CA1063937A (en) 1979-10-09

Family

ID=27276063

Family Applications (1)

Application Number Title Priority Date Filing Date
CA268,779A Expired CA1063937A (en) 1975-12-31 1976-12-29 Composition containing n4-acylcytosine arabinosides and process for preparation thereof

Country Status (5)

Country Link
CA (1) CA1063937A (de)
CH (1) CH619471A5 (de)
DE (1) DE2658406C2 (de)
HU (1) HU180646B (de)
SE (1) SE445011B (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
IL59083A (en) * 1979-01-10 1983-12-30 Israel Marcus Pharmaceutical composition containing thymidine and a salicyclic acid derivative as a solubilizing agent therefor
FR2850278B1 (fr) * 2003-01-24 2005-02-25 Gattefosse Ets Sa Utilisation du 2-hydroxymethyltetrahydropyranne comme excipient dans une composition cosmetique ou pharmaceutique

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5637967B2 (de) * 1973-05-17 1981-09-03

Also Published As

Publication number Publication date
DE2658406C2 (de) 1984-04-26
SE445011B (sv) 1986-05-26
SE7614755L (sv) 1977-07-01
CH619471A5 (en) 1980-09-30
DE2658406A1 (de) 1977-07-07
HU180646B (en) 1983-04-29

Similar Documents

Publication Publication Date Title
US8361990B2 (en) Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
US4722941A (en) Readily absorbable pharmaceutical compositions of per se poorly absorbable pharmacologically active agents and preparation thereof
CN110870868A (zh) 包含亚甲蓝类染料、营养素或/和抗肿瘤化合物的药物组合物及其应用
CN104854081A (zh) 新型的类神经酰胺化合物其及其制备方法
US4289757A (en) Method for treating inflammation
CA1063937A (en) Composition containing n4-acylcytosine arabinosides and process for preparation thereof
Parker et al. N-Trifluoroacetyladriamycin-14-valerate: additional mouse antitumor and toxicity studies
US8034796B2 (en) Glucosamine and glucosamine/anti-inflammatory mutual prodrugs, compositions, and methods
WO2008131260A1 (en) Derivatives of amyris alcohols and eudesmol for treating cold sores and herpes
WO2006074379A2 (en) Methods and compositions involving esters of azelaic acid and other dicarboxylic acids
CN101665449A (zh) 他米巴罗汀的水溶性前药及其制备方法与应用
US20130143872A1 (en) Injectable formulation of a reverse transcriptase inhibitor for the treatment cancer
CN112778369B (zh) 一种三唑类衍生物及其制备方法和用途
WO2016159537A1 (ko) 파이토스핑고신 유도체 및 이를 함유하는 조성물
CN101890014B (zh) 一种哌拉西林钠舒巴坦钠药物组合物脂质体注射剂
CA1285488C (en) Pharmaceutical formulation containing indomethacin
JP2830243B2 (ja) ポリエン含有組成物
JPS5834446B2 (ja) 消炎剤
CA1085730A (en) Treatment of psoriasis with 6-substituted nicotinamides, 2-substituted pyrazinamides and closely related compounds
US2726983A (en) Isonicotinic acid hydrazones and antituberculous compositions thereof
JPH09183729A (ja) 凍結乾燥ウラシルを含有する抗腫瘍医薬組成物
RU2285696C2 (ru) Комплексы включения бутилфталида с циклодекстрином или его производными, способ их получения и их применение
KR19990075252A (ko) 비가역성 hiv프로테아제 억제제를 포함하는 경구투여용 약학적 조성물
PT89465A (pt) Processo para a preparacao de composicoes secas estabilizadas de antibioticos de tipo antraciclina com eficacia citostatica
JPH06279281A (ja) 利胆剤